GlucoTrack, Inc.

GCTK Healthcare Medical Devices

EPS
+92.1%
Free cash flow
+3.42%
Total debt
+777.8%

Quarter to June 2026, against a year earlier

0.30 0.08 −21.05%
Market cap
$1.7M
P/E
0.0×
Fwd P/E
−17.8×
Dividend yield
—
F-score
3/9
Altman Z
26019048.63
Beneish M
2.40
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

— — — —
EV/Sales
— — — —
EV/FCF
— — — —
Current Ratio
1.53 1.61 0.85 0.46
Net Debt/EBITDA
1.08 1.19 0.09 (0.25)
Debt/Equity
1.18 1.21 (4.19) (1.11)
Free Cash Flow Yield
— — — —
Free Cash Flow per Share
(156.27) (191.11) (74.14) (21.64)
Book value per Share
91.70 136.62 (15.59) (10.42)
Free Cash Flow
(4.69) (3.96) (4.05) (3.62)
EV/EBIT
— — — —
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026